Abstract

Experimental and clinical studies (reviewed in Ref. 1) indicate that serum blocking factors may alter immunological and inflammatory responses promoting tumor growth. In recent years, many plasma components including as yet undefined soluble factors especially glyco-proteins have been described as inhibitory in in vitro and in vivo bio-assays. It is still controversial if these factors are tumor products or if they are consequent to a tumor induced host response. In the present study, we investigated the possibility of reducing or eliminating such factors by large volume plasma-exchange with the aim of modulating the host tumor response.KeywordsPlasma ExchangeBlocking ActivityTumor BearingSerum BlockingTritiated Thymidine UptakeThese keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.